Steven Mintz - May 17, 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ Steven Mintz
Stock symbol
SER
Transactions as of
May 17, 2024
Transactions value $
$120,827
Form type
4
Date filed
5/23/2024, 05:07 PM
Previous filing
Apr 3, 2024
Next filing
Jun 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SER Common Stock Purchase $4.71K +554 $8.50 554 May 17, 2024 By Spouse
transaction SER Common Stock Purchase $1.85K +195 +35.2% $9.48 749 May 20, 2024 By Spouse
transaction SER Common Stock Purchase $66.5K +6.65K +887.98% $10.00 7.4K May 21, 2024 By Spouse
transaction SER Common Stock Purchase $24.4K +2.5K +33.78% $9.75 9.9K May 21, 2024 By Spouse
transaction SER Common Stock Purchase $11.7K +1.24K $9.44 1.24K May 20, 2024 By Adult Child 1 F1
transaction SER Common Stock Purchase $11.7K +1.24K $9.42 1.24K May 20, 2024 By Adult Child 2 F2
holding SER Common Stock 3.31K May 17, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
F2 The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
F3 Number of securities determined after giving effect to a reverse split of the Issuer's common stock of 1-for-35.17.